Abstract
Present at the Midyear Clinical Meeting.
This evaluation found that most vaccinated patients met criteria. About 1/3 of newborns received RSV protection, but post-birth nirsevimab use could not be confirmed for non-Parkview patients.
Document Type
Poster
Publication Date
2025
Recommended Citation
Nzekwe, Afamefuna, "Catch flights, not RSV: real-world evaluation of respiratory syncytial virus (RSV) vaccine use in maternal and older adult populations" (2025). Pharmacy Residency. 59.
https://researchrepository.parkviewhealth.org/pharmresidency/59